A clinical trial in The Netherlands with the drug Benralizumab showed that this new asthma medication saves lives. Benralizumab is a monoclonal antibody that attacks eosinophils. They are special hyperreactive immune cells that circulate in the blood of asthmatics. In fact, researcher